A Role for Peroxisome Proliferator-Activated Receptor Gamma Agonists in Counteracting the Degeneration of Cardiovascular Grafts

Aortic valve replacement for severe stenosis is a standard procedure in cardiovascular medicine. However, the use of biological prostheses has limitations especially in young patients because of calcifying degeneration, resulting in implant failure. Pioglitazone, a peroxisome proliferator-activated...

Descripción completa

Detalles Bibliográficos
Autores principales: Assmann, Anna Kathrin, Goschmer, Daniel, Sugimura, Yukiharu, Chekhoeva, Agunda, Barth, Mareike, Assmann, Alexander, Lichtenberg, Artur, Akhyari, Payam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728763/
https://www.ncbi.nlm.nih.gov/pubmed/34654784
http://dx.doi.org/10.1097/FJC.0000000000001150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728763/
https://www.ncbi.nlm.nih.gov/pubmed/34654784
http://dx.doi.org/10.1097/FJC.0000000000001150

Ejemplares similares